


Healthcare News Roundup: Biopharmaceutical
HSMN NewsFeed - 24 Jul 2006
Sirion Therapeutics Acquires U.S. License to Develop New Ophthalmic Compound
Sirion Therapeutics Acquires U.S. License to Develop New Ophthalmic Compound
HSMN NewsFeed - 24 Jul 2006
Debiopharm Applies for First European Marketing Authorisation for Sanvar(R) in France
Debiopharm Applies for First European Marketing Authorisation for Sanvar(R) in France
HSMN NewsFeed - 23 Jul 2006
Nexavar(R) Approved by European Commission for the Treatment of Advanced Kidney Cancer
Nexavar(R) Approved by European Commission for the Treatment of Advanced Kidney Cancer
HSMN NewsFeed - 21 Jul 2006
Pharming Submits Marketing Authorisation Application for Recombinant Human C1 Inhibitor in Europe
Pharming Submits Marketing Authorisation Application for Recombinant Human C1 Inhibitor in Europe
HSMN NewsFeed - 20 Jul 2006
Berlex Issues Nationwide Recall of a Single Lot of Ultravist(R) Injection 370 mgI/mL, 125 mL in the U.S.
Berlex Issues Nationwide Recall of a Single Lot of Ultravist(R) Injection 370 mgI/mL, 125 mL in the U.S.
HSMN NewsFeed - 20 Jul 2006
YM BioSciences reports anti-EGFr drug nimotuzumab approved in India for treatment of head and neck cancer
YM BioSciences reports anti-EGFr drug nimotuzumab approved in India for treatment of head and neck cancer
HSMN NewsFeed - 20 Jul 2006
GSK Announces U.S. Government Purchase of Relenza(R) for State Stockpiles
GSK Announces U.S. Government Purchase of Relenza(R) for State Stockpiles
HSMN NewsFeed - 20 Jul 2006
Leiner Health Products Appoints Kevin McDonnell Executive Vice President, Chief Financial Officer
Leiner Health Products Appoints Kevin McDonnell Executive Vice President, Chief Financial Officer
HSMN NewsFeed - 20 Jul 2006
Poniard Pharmaceuticals Appoints Alan B. Glassberg, M.D., as Chief Medical Officer
Poniard Pharmaceuticals Appoints Alan B. Glassberg, M.D., as Chief Medical Officer
HSMN NewsFeed - 19 Jul 2006
Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Mobic(R)
Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Mobic(R)
HSMN NewsFeed - 19 Jul 2006
Magen BioSciences, Inc. Announces Brian M. Gallagher Joins as President and CEO
Magen BioSciences, Inc. Announces Brian M. Gallagher Joins as President and CEO
HSMN NewsFeed - 19 Jul 2006
Applied NeuroSolutions Announces Intent of John F. DeBernardis to Resign as CEO
Applied NeuroSolutions Announces Intent of John F. DeBernardis to Resign as CEO
HSMN NewsFeed - 19 Jul 2006
Somaxon Pharmaceuticals Provides Update on SILENOR(TM) Development Program for the Treatment of Insomnia
Somaxon Pharmaceuticals Provides Update on SILENOR(TM) Development Program for the Treatment of Insomnia
HSMN NewsFeed - 19 Jul 2006
Myriad's 24-Month Study of Flurizan Demonstrates Significant Benefit in Alzheimer's Disease Patients
Myriad's 24-Month Study of Flurizan Demonstrates Significant Benefit in Alzheimer's Disease Patients
HSMN NewsFeed - 18 Jul 2006
Ranbaxy to Acquire the Mundogen Generic Business of GlaxoSmithKline in Spain
Ranbaxy to Acquire the Mundogen Generic Business of GlaxoSmithKline in Spain
HSMN NewsFeed - 18 Jul 2006
AstraZeneca Submits NDA for Sustained Release Formulation of SEROQUEL(R) for Schizophrenia Treatment
AstraZeneca Submits NDA for Sustained Release Formulation of SEROQUEL(R) for Schizophrenia Treatment
HSMN NewsFeed - 18 Jul 2006
Valeant Pharmaceuticals Announces Availability of Zelapar(R) for Parkinson's Disease Patients
Valeant Pharmaceuticals Announces Availability of Zelapar(R) for Parkinson's Disease Patients
HSMN NewsFeed - 18 Jul 2006
MedImmune Receives Complete Response Letter From FDA for New Formulation of FluMist(R)
MedImmune Receives Complete Response Letter From FDA for New Formulation of FluMist(R)
HSMN NewsFeed - 18 Jul 2006
Antares Pharma Announces Licensing Agreement with Teva for Novel Injector Device
Antares Pharma Announces Licensing Agreement with Teva for Novel Injector Device
HSMN NewsFeed - 18 Jul 2006
King Pharmaceuticals Reports Federal Court Upholds Validity of Altace(R) Patent
King Pharmaceuticals Reports Federal Court Upholds Validity of Altace(R) Patent
HSMN NewsFeed - 18 Jul 2006
Critical Therapeutics Announces Change in Leadership of Specialty Sales Force
Critical Therapeutics Announces Change in Leadership of Specialty Sales Force
HSMN NewsFeed - 17 Jul 2006
Ranbaxy's Joint Venture in Japan Launches Generic Clarithromycin & Terbinafine Tablets
Ranbaxy's Joint Venture in Japan Launches Generic Clarithromycin & Terbinafine Tablets
HSMN NewsFeed - 17 Jul 2006
Bayer HealthCare Introduces Free Product Trial Program For Kogenate(R) FS with BIO-SET(R)
Bayer HealthCare Introduces Free Product Trial Program For Kogenate(R) FS with BIO-SET(R)
HSMN NewsFeed - 17 Jul 2006
Schering-Plough Appoints John M. Carroll Vice President, Global Internal Audits
Schering-Plough Appoints John M. Carroll Vice President, Global Internal Audits
HSMN NewsFeed - 17 Jul 2006
Michael Tansey, M.D. Joins La Jolla Pharmaceutical Company as Chief Medical Officer
Michael Tansey, M.D. Joins La Jolla Pharmaceutical Company as Chief Medical Officer
HSMN NewsFeed - 17 Jul 2006
BioAlliance Pharma Strengthens International Capabilities in Key Legal, IP and Regulatory Departments
BioAlliance Pharma Strengthens International Capabilities in Key Legal, IP and Regulatory Departments
HSMN NewsFeed - 14 Jul 2006
Conjuchem announces clinical hold of its DAC(TM):GRF Program in HIV Lipodystrophy
Conjuchem announces clinical hold of its DAC(TM):GRF Program in HIV Lipodystrophy
HSMN NewsFeed - 13 Jul 2006
AngioDynamics to Be Exclusive Distributor of Sotradecol in All U.S. Markets
AngioDynamics to Be Exclusive Distributor of Sotradecol in All U.S. Markets
HSMN NewsFeed - 13 Jul 2006
Mylan Announces Tentative Approval for Amlodipine Besylate and Benazepril Hydrochloride Capsules
Mylan Announces Tentative Approval for Amlodipine Besylate and Benazepril Hydrochloride Capsules
HSMN NewsFeed - 13 Jul 2006
Geisinger Researchers Discover Ability of Statins to Help Control Danger of Abdominal Aortic Aneurysms
Geisinger Researchers Discover Ability of Statins to Help Control Danger of Abdominal Aortic Aneurysms
HSMN NewsFeed - 13 Jul 2006
Nascent Pharmaceuticals Adds Joanna Horobin, M.D., to Its Board of Directors
Nascent Pharmaceuticals Adds Joanna Horobin, M.D., to Its Board of Directors
HSMN NewsFeed - 13 Jul 2006
Corautus Genetics Announces Partial Lifting of FDA Clinical Hold and Update on GENASIS Database Lock
Corautus Genetics Announces Partial Lifting of FDA Clinical Hold and Update on GENASIS Database Lock
HSMN NewsFeed - 13 Jul 2006
Nastech Pharmaceutical Company Receives FDA Communication Concerning Calcitonin-Salmon Nasal Spray
Nastech Pharmaceutical Company Receives FDA Communication Concerning Calcitonin-Salmon Nasal Spray
HSMN NewsFeed - 13 Jul 2006
Alexion Pharmaceuticals Purchases Biopharmaceutical Manufacturing Site in Rhode Island
Alexion Pharmaceuticals Purchases Biopharmaceutical Manufacturing Site in Rhode Island
HSMN NewsFeed - 12 Jul 2006
AAIPharma Announces Appointment of Vice President of Pharmaceutical Business Development
AAIPharma Announces Appointment of Vice President of Pharmaceutical Business Development
HSMN NewsFeed - 12 Jul 2006
Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Glucotrol(R)
Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Glucotrol(R)
HSMN NewsFeed - 12 Jul 2006
Mutual Pharmaceutical Company/AR Scientific Launches QUALAQUIN(TM) (quinine sulfate capsules USP, 324 mg)
Mutual Pharmaceutical Company/AR Scientific Launches QUALAQUIN(TM) (quinine sulfate capsules USP, 324 mg)
HSMN NewsFeed - 12 Jul 2006
Kos Submits Supplemental New Drug Application To FDA For New Niaspan(R) CF Range of Products
Kos Submits Supplemental New Drug Application To FDA For New Niaspan(R) CF Range of Products
HSMN NewsFeed - 12 Jul 2006
Schering-Plough Announces Executive Changes in Schering-Plough Research Institute
Schering-Plough Announces Executive Changes in Schering-Plough Research Institute
HSMN NewsFeed - 12 Jul 2006
Teva Will Be Sole Promoter of AZILECT(R) for Parkinson's Disease in the United States
Teva Will Be Sole Promoter of AZILECT(R) for Parkinson's Disease in the United States
HSMN NewsFeed - 11 Jul 2006
Panacos Announces Promotion of Graham P. Allaway, Ph.D. to President and Chief Operating Officer
Panacos Announces Promotion of Graham P. Allaway, Ph.D. to President and Chief Operating Officer
HSMN NewsFeed - 11 Jul 2006
Solvay Pharmaceuticals Settles Lawsuit Against Pseudo-Generic to CREON(R) MINIMICROSPHERES(R)
Solvay Pharmaceuticals Settles Lawsuit Against Pseudo-Generic to CREON(R) MINIMICROSPHERES(R)
HSMN NewsFeed - 11 Jul 2006
James L. Freddo, M.D., Joins Anadys Pharmaceuticals as Chief Medical Officer
James L. Freddo, M.D., Joins Anadys Pharmaceuticals as Chief Medical Officer
HSMN NewsFeed - 11 Jul 2006
Gentium Announces Publication of Two Independent Pediatric Studies of Defibrotide
Gentium Announces Publication of Two Independent Pediatric Studies of Defibrotide
HSMN NewsFeed - 11 Jul 2006
Biopure Applies for Marketing Authorization of Hemopure(R) In the United Kingdom
Biopure Applies for Marketing Authorization of Hemopure(R) In the United Kingdom
HSMN NewsFeed - 10 Jul 2006
Manhattan Pharmaceuticals Names Michael G. McGuinness as Chief Financial Officer
Manhattan Pharmaceuticals Names Michael G. McGuinness as Chief Financial Officer
HSMN NewsFeed - 10 Jul 2006
Human Genome Sciences Names Timothy C. Barabe Senior Vice President and Chief Financial Officer
Human Genome Sciences Names Timothy C. Barabe Senior Vice President and Chief Financial Officer
HSMN NewsFeed - 10 Jul 2006
FDA Issues Approvable Letter to Cellegy Pharmaceuticals for Cellegesic(R)
FDA Issues Approvable Letter to Cellegy Pharmaceuticals for Cellegesic(R)
HSMN NewsFeed - 10 Jul 2006
ARCA Discovery, Inc. Names Dr. Ann Lenich Hards Executive Vice President Regulatory Affairs
ARCA Discovery, Inc. Names Dr. Ann Lenich Hards Executive Vice President Regulatory Affairs
HSMN NewsFeed - 10 Jul 2006
AnorMED completes enrollment in Phase III trial for MOZOBIL in stem cell transplant in multiple myeloma
AnorMED completes enrollment in Phase III trial for MOZOBIL in stem cell transplant in multiple myeloma
HSMN NewsFeed - 10 Jul 2006
European Commission Approves Revision of Therapeutic Indication for Rebif(R)
European Commission Approves Revision of Therapeutic Indication for Rebif(R)
HSMN NewsFeed - 7 Jul 2006
Nektar and University of Alabama in Huntsville Announce Agreement to Settle Litigation
Nektar and University of Alabama in Huntsville Announce Agreement to Settle Litigation
HSMN NewsFeed - 7 Jul 2006
Indevus Announces Positive Data from Second Phase III Trial for SANCTURA XR(TM) in Overactive Bladder
Indevus Announces Positive Data from Second Phase III Trial for SANCTURA XR(TM) in Overactive Bladder
HSMN NewsFeed - 6 Jul 2006
ZARS Pharma Announces FDA Approval of a Topical Local Anesthetic Peel (Lidocaine and Tetracaine) 7%/7%
ZARS Pharma Announces FDA Approval of a Topical Local Anesthetic Peel (Lidocaine and Tetracaine) 7%/7%
HSMN NewsFeed - 6 Jul 2006
AtheroGenics Announces Promotion of Joseph M. Gaynor, Jr. to Senior Vice President
AtheroGenics Announces Promotion of Joseph M. Gaynor, Jr. to Senior Vice President
HSMN NewsFeed - 6 Jul 2006
King Pharmaceuticals and Wyeth Announce Restructuring of Co-Promotion Agreement for ALTACE(R)
King Pharmaceuticals and Wyeth Announce Restructuring of Co-Promotion Agreement for ALTACE(R)
HSMN NewsFeed - 6 Jul 2006
Angiotech appoints Jeffrey P. Walker as Senior Vice President, Research and Development
Angiotech appoints Jeffrey P. Walker as Senior Vice President, Research and Development
HSMN NewsFeed - 6 Jul 2006
Cardinal Health Acquires Positron Emission Tomography (PET) Radiopharmaceutical Production Facilities
Cardinal Health Acquires Positron Emission Tomography (PET) Radiopharmaceutical Production Facilities
HSMN NewsFeed - 6 Jul 2006
Eisai Inc. Announces Appointment of Vice President of Business Development
Eisai Inc. Announces Appointment of Vice President of Business Development
HSMN NewsFeed - 6 Jul 2006
MedImmune Receives FDA Approval to Use Reverse Genetics Technology for FluMist(R) Vaccine Production
MedImmune Receives FDA Approval to Use Reverse Genetics Technology for FluMist(R) Vaccine Production
HSMN NewsFeed - 6 Jul 2006
Nuvelo Announces Publication of Phase 2 Alfimeprase Study Results in Central Venous Catheter Occlusion
Nuvelo Announces Publication of Phase 2 Alfimeprase Study Results in Central Venous Catheter Occlusion
HSMN NewsFeed - 6 Jul 2006
Alexion Pharmaceuticals Appoints David L. Hallal Vice President U.S. Commercial Operations
Alexion Pharmaceuticals Appoints David L. Hallal Vice President U.S. Commercial Operations
HSMN NewsFeed - 5 Jul 2006
Cardinal Health Aligns Manufacturing Businesses, Names International President
Cardinal Health Aligns Manufacturing Businesses, Names International President
HSMN NewsFeed - 5 Jul 2006
NovaDel Announces Filing of NDA for the Zensana(TM) (Ondansetron HCl) Oral Spray
NovaDel Announces Filing of NDA for the Zensana(TM) (Ondansetron HCl) Oral Spray
HSMN NewsFeed - 4 Jul 2006
Data Show CHANTIX(TM) (varenicline) Provides Smokers New Hope to Quit Smoking
Data Show CHANTIX(TM) (varenicline) Provides Smokers New Hope to Quit Smoking
HSMN NewsFeed - 3 Jul 2006
Abbott's New Tablet Formulation of Kaletra(R) (lopinavir/ritonavir) Approved in Europe
Abbott's New Tablet Formulation of Kaletra(R) (lopinavir/ritonavir) Approved in Europe
HSMN NewsFeed - 30 Jun 2006
FDA Approves LUCENTIS for the Treatment of Wet Age-Related Macular Degeneration
FDA Approves LUCENTIS for the Treatment of Wet Age-Related Macular Degeneration
HSMN NewsFeed - 30 Jun 2006
EPIX Pharmaceuticals Files Appeal with FDA Regarding Vasovist(TM) Approvable Letters
EPIX Pharmaceuticals Files Appeal with FDA Regarding Vasovist(TM) Approvable Letters
HSMN NewsFeed - 30 Jun 2006
Par Pharmaceutical Receives Final Approval to Market Tranylcypromine Sulfate Tablets
Par Pharmaceutical Receives Final Approval to Market Tranylcypromine Sulfate Tablets
HSMN NewsFeed - 29 Jun 2006
REVLIMID(R) in Combination With Dexamethasone sNDA Granted Approval By FDA for Treatment of Multiple Myeloma
REVLIMID(R) in Combination With Dexamethasone sNDA Granted Approval By FDA for Treatment of Multiple Myeloma
HSMN NewsFeed - 29 Jun 2006
sanofi-aventis Announces Update to Ketek(R) (Telithromycin) U.S. Prescribing Information
sanofi-aventis Announces Update to Ketek(R) (Telithromycin) U.S. Prescribing Information
HSMN NewsFeed - 29 Jun 2006
FDA Grants Fast Track Designation for TargeGen TG100-115 Cardiovascular Compound
FDA Grants Fast Track Designation for TargeGen TG100-115 Cardiovascular Compound
HSMN NewsFeed - 29 Jun 2006
Nabi Biopharmaceuticals Secures Agreement with Kedrion to Co-Develop and Commercialize Civacir(R) in Europe
Nabi Biopharmaceuticals Secures Agreement with Kedrion to Co-Develop and Commercialize Civacir(R) in Europe
HSMN NewsFeed - 29 Jun 2006
Noven Confirms Availability of Daytrana(TM) Methylphenidate Transdermal System
Noven Confirms Availability of Daytrana(TM) Methylphenidate Transdermal System
HSMN NewsFeed - 29 Jun 2006
Nuvelo Expands Depth in Manufacturing and Development With Key Additions to Management Team
Nuvelo Expands Depth in Manufacturing and Development With Key Additions to Management Team
HSMN NewsFeed - 28 Jun 2006
Therion Reports Results of Phase 3 PANVAC-VF Trial and Announces Plans for Company Sale
Therion Reports Results of Phase 3 PANVAC-VF Trial and Announces Plans for Company Sale
HSMN NewsFeed - 28 Jun 2006
Adolor Corporation Appoints Scott T. Megaffin as Vice President, Marketing
Adolor Corporation Appoints Scott T. Megaffin as Vice President, Marketing
HSMN NewsFeed - 28 Jun 2006
Nereus Pharmaceuticals Appoints Dr. Charles White as Chief Business Officer
Nereus Pharmaceuticals Appoints Dr. Charles White as Chief Business Officer
HSMN NewsFeed - 28 Jun 2006
King Pharmaceuticals and Depomed Announce Agreement to Co-Promote Glumetza(TM)
King Pharmaceuticals and Depomed Announce Agreement to Co-Promote Glumetza(TM)
HSMN NewsFeed - 28 Jun 2006
EntreMed Granted Orphan Drug Designation for Panzem(R) (2ME2) In Glioblastoma
EntreMed Granted Orphan Drug Designation for Panzem(R) (2ME2) In Glioblastoma
HSMN NewsFeed - 28 Jun 2006
Smith & Nephew and Q-MED Enter Into Strategic Alliance in Osteoarthritis Treatment
Smith & Nephew and Q-MED Enter Into Strategic Alliance in Osteoarthritis Treatment
HSMN NewsFeed - 27 Jun 2006
Cameron Groome Joins Bioniche as Executive Vice-President, Corporate & Strategic Development
Cameron Groome Joins Bioniche as Executive Vice-President, Corporate & Strategic Development
HSMN NewsFeed - 27 Jun 2006
Halozyme and Baxter Announce Availability of Hylenex for Subcutaneous Delivery of Medications and Fluids
Halozyme and Baxter Announce Availability of Hylenex for Subcutaneous Delivery of Medications and Fluids
HSMN NewsFeed - 27 Jun 2006
Phase III Study of Avastin(R) in Advanced Pancreatic Cancer Does Not Meet Primary Endpoint
Phase III Study of Avastin(R) in Advanced Pancreatic Cancer Does Not Meet Primary Endpoint
